Skip to main content
. 2019 Jan 28;108(8):868–877. doi: 10.1007/s00392-019-01415-z

Table 2.

Event rates and hazard ratios for all outcomes according to diabetes status of patients in the placebo and ICD group

Events (n) Crude rate per 100 py (95% CI) Unadjusted HR (95% CI) p values Adjusted HRa (95% CI) p values
All-cause mortality
 Diabetes 187 10.8 (9.4–12.5) 1.80 (1.49–2.18) < 0.0001 1.50 (1.23–1.83) < 0.0001
 No diabetes 239 6.1 (5.3–6.9) 1.00 (ref.) 1.00 (ref.)
CV death
 Diabetes 128 7.4 (6.2–8.8) 1.82 (1.44–2.30) < 0.0001 1.52(1.19–1.93) 0.001
 No diabetes 161 4.1 (3.5–4.8) 1.00 (ref.) 1.00 (ref.)
Sudden cardiac death
 Diabetes 63 3.7 (2.9–4.7) 2.02 (1.44–2.83) < 0.0001 1.73 (1.22–2.47) 0.002
 No diabetes 71 1.8 (1.4–2.3) 1.00 (ref.) 1.00 (ref.)
Non-sudden CV death
 Diabetes 124 7.2 (6.0-8.6) 1.71 (1.36–2.16) < 0.0001 1.42 (1.11–1.80) 0.005
 No diabetes 168 4.3 (3.7–4.9) 1.00 (ref.) 1.00 (ref.)

HR hazard ratio, py person years, CV cardiovascular, ref reference

aAdjusted for age, gender, randomization to ICD implantation, NYHA class, left ventricular ejection fraction, duration of HF, HF etiology, systolic blood pressure, creatinine, history of atrial fibrillation, stroke and pulmonary disease